FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MG Gilligan

Research Profile

Chemicals & Drugs

Procedures

Genetic Therapy

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
SJ Weedon; Nicola K Green; Iain A McNeish; MG Gilligan; Vivien Mautner; Christopher J Wrighton; Andrew Mountain; Lawrence S Young; David J Kerr; Peter F Searle
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.
MG Gilligan; P G Knox; Peter F Searle
Gene therapy: development of immunostimulatory treatments for cancer.
P A Gerin; MG Gilligan; Peter F Searle; Mohamed Al-Rubeai
Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MG Gilligan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: SJ Weedon; Nicola K Green; Iain A McNeish; MG Gilligan; Vivien Mautner; Christopher J Wrighton; Andrew Mountain; Lawrence S Young; David J Kerr; Peter F Searle
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.
International journal of cancer. Journal international du cancer 2000;86(6):848-54.
2000: MG Gilligan; P G Knox; Peter F Searle
Gene therapy: development of immunostimulatory treatments for cancer.
Biotechnology & genetic engineering reviews 2000;17():497-529.
1999: P A Gerin; MG Gilligan; Peter F Searle; Mohamed Al-Rubeai
Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium.
Human gene therapy 1999;10(12):1965-74.
1998: Iain A McNeish; Nicola K Green; MG Gilligan; MJ Ford; Vivien Mautner; Lawrence S Young; David J Kerr; Peter F Searle
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954.
Gene therapy 1998;5(8):1061-9.
1998: MG Gilligan; P Knox; SJ Weedon; R Barton; David J Kerr; Peter F Searle; Lawrence S Young
Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells.
Gene therapy 1998;5(7):965-74.
1998: Peter F Searle; SJ Weedon; Iain A McNeish; MG Gilligan; MJ Ford; Frank Friedlos; Caroline J Springer; Lawrence S Young; David J Kerr
Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene.
Advances in experimental medicine and biology 1998;451():107-13.
1996: Kevin Docherty; Wendy M Macfarlane; Martin L Read; S B Smith; M E Wilson; Iwona J Bujalska; MG Gilligan
Regulation of insulin gene transcription by nutrients.
Biochemical Society transactions 1996;24(2):368-72.
1996: MG Gilligan; Gavin I Welsh; A Flynn; Iwona J Bujalska; TA Diggle; Richard M Denton; Christopher G Proud; Kevin Docherty
Glucose stimulates the activity of the guanine nucleotide-exchange factor eIF-2B in isolated rat islets of Langerhans.
The Journal of biological chemistry 1996;271(4):2121-5.
1994: Wendy M Macfarlane; Martin L Read; MG Gilligan; Iwona J Bujalska; Kevin Docherty
Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner.
The Biochemical journal 1994;303 ( Pt 2)():625-31.
1990: J Perry; MG Gilligan; E Green; Hilary M Docherty; D Heath
Monoclonal antibodies to ROS 17/2.8 cells recognize antigens, some of which are restricted to osteoblasts and chondrocytes.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1990;5(2):187-200.